• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

St. Louis

Merck KGaA MilliporeSigma US
Manufacturing

MilliporeSigma's production push rolls with $76M ADC investment

MilliporeSigma, a unit of Germany's Merck KGaA, revealed plans to pump $76 million into expanding production capacity at its ADC facility in St. Louis.
Joseph Keenan Oct 29, 2024 10:33am
Thermo Fisher Scientific headquarters

Thermo Fisher to pump $82.5M into St. Louis biologics plant

Sep 28, 2021 9:20am
jnj

On heels of New Jersey talc win, J&J scores again in California

Apr 8, 2019 11:05am
jnj

Second straight talc case against J&J ends in mistrial

Oct 3, 2018 11:31am
courthouse

Judge affirms multibillion-dollar talc verdict against J&J

Aug 23, 2018 10:17am
courthouse

High-stakes talc trial ends in $4.7B verdict for J&J

Jul 13, 2018 10:00am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings